The prognostic factors in acute myeloid leukaemia with double‐mutated CCAAT/enhancer‐binding protein alpha <scp> ( <i>CEBPA</i> dm </scp> )-Reference-Cited by-同舟云学术

The prognostic factors in acute myeloid leukaemia with double‐mutated CCAAT/enhancer‐binding protein alpha ( CEBPA dm )

Published:2022-03-10 Issue:4 Volume:197 Page:442-451
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wei Hui¹²³⁴^ORCID,Zhou Chunlin⁴,Liu Bingcheng⁴,Lin Dong⁴,Li Yan⁴,Wei Shuning⁴,Gong Benfa⁴,Zhang Guangji⁴,Liu Kaiqi⁴,Gong Xiaoyuan⁴,Fang Qiuyun⁴,Liu Yuntao⁴,Qiu Shaowei⁴,Gu Runxia⁴,Song Zhen²,Chen Jiayuan¹,Yang Miao¹^ORCID,Zhang Junping⁴,Jin Jingjing⁴,Wang Ying²⁴,Mi Yingchang¹²³⁴,Wang Jianxiang¹²³⁴^ORCID

Affiliation:

1. State Key laboratory of Experimental Hematolog Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin China

2. National Clinical Research Center for Blood Disease Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin China

3. Haihe Laboratory of Cell Ecosystem Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin China

4. Leukemia center Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18113

Reference21 articles.

1. Acute Myeloid Leukemia

2. Acute myeloid leukaemia in adults

3. Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population

4. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

5. National Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia Version 3.2020. Available from: http://nccndd.qitian‐med.tech/nccn‐his/%E6%80%A5%E6%80%A7%E9%AB%93%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85/%E6%80%A5%E6%80%A7%E9%AB%93%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%852020.3%E7%89%88.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications;Blood Cancer Journal;2024-04-09

2. CACA guidelines for holistic integrative management of adult acute myeloid leukemia;Holistic Integrative Oncology;2024-03-14

3. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations;Blood Cancer Journal;2024-01-23

4. Immunophenotype distinctions of CEBPA mutation subtypes in acute myeloid leukemia;International Journal of Laboratory Hematology;2023-06-19

5. Heterogeneity analysis of the CEBPAdm AML based on bZIP region mutations;Blood Science;2023-03-06